N. Zhang

发表

Gene Therapy in Orthotopic Lung Cancer Murine Model with Angiogenesis Inhibitor, Endostatin

Y. Guan, Shasha Jiang, Zejun Lu, 2008 .

Long-term survival of non-small-cell lung cancer patients with EGFR inhibitor treatment.

Maoxiu Zhang, H. M. Gao, Y. S. Wang, 2014, Genetics and molecular research : GMR.

Case report: Kidney perivascular epithelioid cell tumor treated with anti-VEGFR tyrosine kinase inhibitor and MTOR inhibitor

L. Wen, Yusheng Wang, Xuting Zhang, 2022, Frontiers in Oncology.

LRG1 Suppresses Migration and Invasion of Esophageal Squamous Cell Carcinoma by Modulating Epithelial to Mesenchymal Transition

Bin Wang, Yusheng Wang, Lei Zhao, 2020, Journal of Cancer.

Radiosensitization of HER2-positive esophageal cancer cells by pyrotinib

Haishan Lin, B. Cao, Guang-Yi Li, 2020, Bioscience reports.

Gene therapy with the angiogenesis inhibitor endostatin in an orthotopic lung cancer murine model.

Y. Guan, Jin-liang Yang, Guo-Ping Wang, 2009, Human gene therapy.

Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma

Yusheng Wang, Suxiang Zhang, Jian Zhao, 2019, Investigational New Drugs.

Tumor-Associated Macrophage-Derived Exosomes Promote the Progression of Gastric Cancer by Regulating the P38MAPK Signaling Pathway and the Immune Checkpoint PD-L1.

Yusheng Wang, B. Cao, Jian Zhao, 2021, Cancer biotherapy & radiopharmaceuticals.

481P A phase I first-in-human study of XL092 in patients (pts) with locally advanced or metastatic solid tumors: Results from dose-escalation of XL092 alone and in combination with atezolizumab

A. Patnaik, V. Subbiah, M. Schwickart, 2022, Annals of Oncology.